Who has invested in Abbisko Therapeutics?

Temasek, Qiming Venture Partners, Lilly Asia Venture are named among the investors backing Abbisko Therapeutics.

Abbisko Therapeutics Funding: $235M Raised, IPO (2021)

Abbisko Therapeutics funding overview

Abbisko Therapeutics has raised $235M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in October 2021. The round record for Abbisko Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Temasek, Qiming Venture Partners, Lilly Asia Venture. 3 distinct backers are named across the disclosed rounds.

Abbisko Therapeutics at a glance

Total raised: $235M
Latest round: IPO
Latest round date: October 2021
Notable investors: Temasek, Qiming Venture Partners, Lilly Asia Venture

Frequently asked about Abbisko Therapeutics funding

How much has Abbisko Therapeutics raised?: Abbisko Therapeutics has raised $235M in total disclosed funding across the rounds on record.
Who has invested in Abbisko Therapeutics?: Temasek, Qiming Venture Partners, Lilly Asia Venture are named among the investors backing Abbisko Therapeutics.
What was the latest Abbisko Therapeutics funding round?: The most recent disclosed round is an IPO, announced in October 2021.
Where is Abbisko Therapeutics based?: No headquarters location is disclosed for Abbisko Therapeutics.
When did Abbisko Therapeutics last raise?: The last disclosed Abbisko Therapeutics round closed in October 2021 at IPO.

Round data for Abbisko Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.

Abbisko Therapeutics Funding: $235M Raised, IPO (2021)

Abbisko Therapeutics funding overview

Abbisko Therapeutics at a glance

Frequently asked about Abbisko Therapeutics funding

Companies related to Abbisko Therapeutics (18)

Browse related funding lists (5)